Molecular Determinants of Radiation Response in Non-Small Cell Lung Cancer

被引：9
|
作者：
Yom, Sue S. [1 ]
Diehn, Maximilian [2 ,3 ]
Raben, David [4 ]
机构：
[1] Univ Calif San Francisco, Dept Radiat Oncol, San Francisco, CA USA
[2] Stanford Univ, Dept Radiat Oncol, Stanford Canc Inst, Stanford, CA 94305 USA
[3] Stanford Univ, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA
[4] Univ Colorado Hlth, Dept Radiat Oncol, Aurora, CO 80045 USA
来源：
SEMINARS IN RADIATION ONCOLOGY | 2015年 / 25卷 / 02期
关键词：
GROWTH-FACTOR RECEPTOR; PHASE-I COMBINATION; POLY(ADP-RIBOSE) POLYMERASE; THORACIC RADIATION; CLINICAL-TRIAL; BREAST-CANCER; TGF-BETA; SYNTHETIC LETHALITY; NEGATIVE REGULATION; IONIZING-RADIATION;
D O I：
10.1016/j.semradonc.2014.12.007
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Non-small cell lung cancers are now recognized to contain considerable heterogeneity and molecular diversity. Substantial progress has been made regarding molecular determinants of response to targeted agents in advanced lung cancer, and recent findings have revealed subsets of patients with driver mutations that respond rapidly to selective inhibitors. In addition, new approaches to disrupting DNA repair and inflammation and activation of the immune system are being explored. A key question in the field is whether therapeutic multimodality options incorporating radiation therapy can capitalize on the gains made in systemic therapy. (C) 2015 Elsevier Inc. All rights reserved.
引用
收藏
页码：67 / 77
页数：11
相关论文
共 50 条
  • [21] Adaptive radiation therapy for non-small cell lung cancer
    Bibault, J. -E.
    Arsene-Henry, A.
    Durdux, C.
    Mornex, F.
    Hamza, S.
    Trouette, R.
    Thureau, S.
    Faivre, J. -C.
    Boisselier, P.
    Lerouge, D.
    Paragios, N.
    Giraud, P.
    CANCER RADIOTHERAPIE, 2015, 19 (6-7): : 458 - 462
  • [22] Accelerated radiation therapy in non-small cell lung cancer
    Baumann, M
    RADIOTHERAPY AND ONCOLOGY, 1999, 52 (02) : 97 - 99
  • [23] Postoperative Radiation Therapy for Non-Small Cell Lung Cancer
    Decker, Roy H.
    Wilson, Lynn D.
    SEMINARS IN THORACIC AND CARDIOVASCULAR SURGERY, 2008, 20 (03) : 184 - 187
  • [24] Lung pathology: The molecular genetics of non-small cell lung cancer
    Fong, KM
    Zimmerman, PV
    Smith, PJ
    PATHOLOGY, 1995, 27 (04) : 295 - 301
  • [25] Molecular Radiobiology in Non-Small Cell Lung Cancer: Prognostic and Predictive Response Factors
    Peinado-Serrano, Javier
    Carnero, Amancio
    CANCERS, 2022, 14 (09)
  • [26] Molecular markers and prediction of response to immunotherapy in non-small cell lung cancer, an update
    Blons, Helene
    Garinet, Simon
    Laurent-Puig, Pierre
    Oudart, Jean-Baptiste
    JOURNAL OF THORACIC DISEASE, 2019, 11 : S25 - S36
  • [27] Response to Checkpoint Inhibition in Non-Small Cell Lung Cancer with Molecular Driver Alterations
    Kauffmann-Guerrero, Diego
    Tufman, Amanda
    Kahnert, Kathrin
    Bollmann, Benjamin Alexander
    Reu, Simone
    Syunyaeva, Zulfiya
    Schneider, Christian
    Manapov, Farkhad
    Huber, Rudolf M.
    Golpon, Heiko
    ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 (06) : 289 - 297
  • [28] Molecular Diagnostic Testing in Non-Small Cell Lung Cancer
    Naidoo, Jarushka
    Drilon, Alexander
    AMERICAN JOURNAL OF HEMATOLOGY-ONCOLOGY, 2014, 10 (04) : 4 - 11
  • [29] The diagnosis of non-small cell lung cancer in the molecular era
    Brainard, Jennifer
    Farver, Carol
    MODERN PATHOLOGY, 2019, 32 : 16 - 26
  • [30] Molecular Pathology of Primary Non-small Cell Lung Cancer
    Suster, David Ilan
    Mino-Kenudson, Mari
    ARCHIVES OF MEDICAL RESEARCH, 2020, 51 (08) : 784 - 798
12345